Lv01
0 积分 2025-09-12 加入
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
52分钟前
已完结
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer
54分钟前
已完结
Co‐Delivery of Multiple RNAs via Lipid Nanoparticles Enables Precise Gene Editing of CAR‐T Cells
1个月前
已完结
Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice
1个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
2个月前
已完结
Overcoming solid-tumor barriers: armored CAR-T cell therapy
2个月前
已完结
皖公网安备34019202002308
